Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without ...

Labour Codes do not create flexible work environment legal, rate cuts may revive market sentiments, nominal GDP of over $11 ...

Novo Nordisk stock price has suffered a harsh reversal this year as the company’s woes have escalated. What next for the stock?

Alphabet stock continues its surge on the back of excitement around Google’s latest large-language model, while Tesla rises ...

The market for GLP-1 medications is already huge, and is expected to explode. It was valued at about $52 billion in 2024; ...

Just in time for the holiday season, Lilly unveiled its multi-pronged campaign to tie in Alzheimer’s awareness with cultural ...

This summer an Indianapolis residence on a meticulously landscaped lot sold after being listed for $5.58 million. The home on Willow Spring Road has six bedrooms and 14 bathrooms. It also features ...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

The studies offer perhaps the most concrete rebuttal yet to an idea that GLP-1 drugs, which have profound benefits on weight ...

Eli Lilly and Novo Nordisk are collaborating with Waltz Health to launch direct-to-employer access for obesity management medications. Waltz Health gave no information on the prices of GLP-1 drugs ...

Novo Nordisk's stock fell after semaglutide's Alzheimer's news. Click here for how strong fundamentals and growth catalysts ...